Sign in to follow
Search Results

0 results for 'Cardinal Health Systems Inc'

You can use to get even better search results
June 03, 2015 |

J&J Acquires Cordis Unit for $2B

Medical device and pharmaceutical company Johnson & Johnson, based in New Brunswick, said on May 28 that it will acquire Cardinal Health's Cordis medical device unit for $2 billion.
1 minute read
June 02, 2015 | Law.com

J&J Acquires Cordis Unit for $2B

Medical device and pharmaceutical company Johnson & Johnson, based in New Brunswick, said on May 28 that it will acquire Cardinal Health's Cordis medical device unit for $2 billion.
1 minute read
May 13, 2015 |

Lifetime Achievement Award Winners

The following attorneys were selected for Lifetime Achievement Awards.
26 minute read
May 11, 2015 | Law.com

Lifetime Achievement Award Winners

The following attorneys were selected for Lifetime Achievement Awards.
26 minute read
April 27, 2015 |

Big Deals

10 minute read
Law Journal Press | Digital Book Health Care Benefits Law Authors: Jeffrey D. Mamorsky View this Book

View more book results for the query "Cardinal Health Systems Inc"

April 27, 2015 | Law.com

Big Deals

AbbVie Inc. / Pharmacyclics Inc. North Chicago, Illinois-based biopharmaceutical company AbbVie Inc. said March 4 it will buy Sunnyvale, California-based…
10 minute read
March 06, 2015 |

J&J Sells Cordis for About $2B

Manufacturing conglomerate Johnson & Johnson in New Brunswick, New Jersey, announced on March 2 that its subsidiary, Freemont, California-based medical device maker Cordis, has been sold to health-care company Cardinal Health, of Dublin, Ohio, for $1.944 billion in cash.
1 minute read
March 06, 2015 | Law.com

J&J Sells Cordis for About $2B

Manufacturing conglomerate Johnson & Johnson in New Brunswick, New Jersey, announced on March 2 that its subsidiary, Freemont, California-based medical device maker Cordis, has been sold to health-care company Cardinal Health, of Dublin, Ohio, for $1.944 billion in cash.
1 minute read
March 05, 2015 |

Deal Watch: Three Am Law Firms Lead on AbbVie's $21 Billion Pharma Buy

Big Pharma tops our latest roundup of deals worth $1 billion or more, with AbbVie Inc. agreeing to purchase cancer-drug maker Pharmacyclics Inc. for $21 billion. Skadden, Arps, Slate, Meagher & Flom advised on the most number of billion-dollar deals this week, with four, while Wachtell, Lipton, Rosen & Katz led the way by transaction value.
5 minute read
March 05, 2015 | Law.com

Deal Watch: Three Am Law Firms Lead on AbbVie's $21 Billion Pharma Buy

Big Pharma tops our latest roundup of deals worth $1 billion or more, with AbbVie Inc. agreeing to purchase cancer-drug maker Pharmacyclics Inc. for $21 billion. Skadden, Arps, Slate, Meagher & Flom advised on the most number of billion-dollar deals this week, with four, while Wachtell, Lipton, Rosen & Katz led the way by transaction value.
5 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now

    • Practical Guidance Journal: Protecting Work Product in a Generative AI World

      Brought to you by LexisNexis®

      Download Now